Skip to main content

Month: June 2024

Purpose Investments Inc. Announces 2024 Second Quarter Distributions for Purpose Specialty Lending Trust

TORONTO, June 25, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the 2024 second-quarter distributions for Purpose Specialty Lending Trust.  TickerSymbol Distributionpershare/unit ExDistributionDate RecordDate PayableDatePurpose Specialty Lending Trust – Class A Unlisted $ 0.1160 06/28/2024 06/28/2024 07/22/2024Purpose Specialty Lending Trust – Class F Unlisted $ 0.1200 06/28/2024 06/28/2024 07/22/2024Purpose Specialty Lending Trust – Class U Unlisted US$ 0.1520 06/28/2024 06/28/2024 07/22/2024Purpose Specialty Lending Trust – Class A1, Series 2 Unlisted $ 0.1345 06/28/2024 06/28/2024 07/22/2024Purpose Specialty Lending Trust – Class F, Series 3 Unlisted $ 0.1390 06/28/2024 06/28/2024 07/22/2024About Purpose Investments Inc. Purpose Investments Inc. is an asset management company with...

Continue reading

Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND submission to the FDA Engaging regulatory authorities to align on ATI-1801 development plans  HALIFAX, Nova Scotia, June 25, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the fiscal year ended March 31, 2024 (“FYE 2024”), and provided an update on the Company’s strategy for fiscal 2025. All figures are stated in Canadian dollars unless otherwise stated. “Notably, during this past fiscal year, the Company’s most...

Continue reading

Middlefield Announces Intention to Merge Middlefield Global Real Asset Fund Into Real Estate Split Corp.

TORONTO, June 25, 2024 (GLOBE NEWSWIRE) — Middlefield Limited (the “Manager”), the manager of Middlefield Global Real Asset Fund (“Real Asset”), is pleased to announce that Real Asset intends to merge into Real Estate Split Corp., a split share corporation founded on November 19, 2020, which invests in a diversified, actively managed, high conviction portfolio of issuers engaged in e-commerce and data infrastructure as well as the multi-family, industrial, retail, seniors housing and healthcare sectors (the “Merger”). The investment objectives of Real Estate Split Corp. are to provide:                Holders of Class A shares with:                           (i) non-cumulative monthly cash distributions; and                           (ii) the opportunity for capital appreciation through exposure to Real Estate Split Corp’s portfolio;...

Continue reading

Middlefield Announces Intention to Merge Middlefield Global Real Asset Fund Into Real Estate Split Corp.

TORONTO, June 25, 2024 (GLOBE NEWSWIRE) — Middlefield Limited (the “Manager”), the manager of Middlefield Global Real Asset Fund (“Real Asset”), is pleased to announce that Real Asset intends to merge into Real Estate Split Corp., a split share corporation founded on November 19, 2020, which invests in a diversified, actively managed, high conviction portfolio of issuers engaged in e-commerce and data infrastructure as well as the multi-family, industrial, retail, seniors housing and healthcare sectors (the “Merger”). The investment objectives of Real Estate Split Corp. are to provide:                Holders of Class A shares with:                              (i) non-cumulative monthly cash distributions; and                              (ii) the opportunity for capital appreciation through exposure to Real Estate Split Corp’s...

Continue reading

Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting

ANX005-Treated Patients Demonstrated Faster and More Complete Recovery from Week 1 through Week 26 on Primary and Multiple Pre-Specified Endpoints Two and a Half Times More ANX005-Treated Patients Returned to a Normal / Pre-Disease State of Health Over Placebo on GBS-DS by Week 26, Increasing Over Time ANX005 Beneficial Impact Larger in Patients with North American and European Baseline Characteristics Across Key Measures of Disability and Muscle Strength Single Infusion of ANX005 was Generally Well-Tolerated with Safety Profile Similar to Placebo Data Reinforce Potential of ANX005 to be First Targeted Immunotherapy Treatment for GBS BRISBANE, Calif., June 25, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), today announced positive results from the completed pivotal Phase 3 trial of C1q-targeted immunotherapy, ANX005,...

Continue reading

authID Announces Pricing of Approximately $11,000,000 Million Registered Direct Offering

DENVER, June 25, 2024 (GLOBE NEWSWIRE) — authID Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of innovative biometric identity verification and authentication solutions, today announced it has entered into a definitive agreement with investors to sell 1,464,965 shares of its common stock (the “Shares”), pursuant to a registered direct offering (the “Registered Direct Offering”). The purchase price for one Share will be $7.50 (however, if the Purchaser is a director of the Company, the Per Share Purchase Price will be $8.16). The aggregate gross proceeds from the Registered Direct Offering are expected to be approximately $11,000,000 million before deducting placement agent fees and other estimated offering expenses. The closing of the Registered Direct Offering is expected to occur on or about June 27, 2024,...

Continue reading

FLINT Announces Voting Results from Shareholders’ Meeting

CALGARY, Alberta, June 25, 2024 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT”) (TSX: FLNT) is pleased to announce that all matters presented for approval at its annual and special meeting (the “Meeting”) of holders of common shares (“Common Shares”) held earlier today were approved. A total of 25,160,259 Common Shares, representing approximately 22.87% of the issued and outstanding Common Shares, were represented at the Meeting. All of the nominees listed in FLINT’s management information circular dated May 10, 2024 (the “Information Circular”) were elected as directors of FLINT to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The results of the vote were:    Votes For   Votes WitheldNominee   #   %   #   %Barry Card   24,347,143   97.20   702,256   2.80H....

Continue reading

Melcor announces election of directors

EDMONTON, Alberta, June 25, 2024 (GLOBE NEWSWIRE) — Melcor Developments Ltd. (TSX: MRD), an Alberta-based real estate development and asset management company, announced the results of its annual general meeting (AGM), held today. A total of 24,498,823 shares were voted in person or by proxy, representing 80.23% of the outstanding shares as of the record date. Shareholders approved all items of business before the AGM, including the election of directors as follows:Nominee Votes For % Votes For Votes Withheld % Votes WithheldDouglas Goss 23,421,560 96.00% 974,980 4.00%Andrew Melton 23,050,408 94.48% 1,346,132 5.52%Kathleen Melton 23,412,750 95.97% 983,790 4.03%Timothy Melton 23,420,760 96.00% 975,780 4.00%Bruce Pennock 23,422,360 96.01% 974,180 3.99%Janet Riopel 23,420,850 96.00% 975,690 4.00%Catherine Roozen 23,298,950 95.50% 1,097,590 4.50%Ralph...

Continue reading

Melcor REIT announces election of trustees

EDMONTON, Alberta, June 25, 2024 (GLOBE NEWSWIRE) — Melcor Real Estate Investment Trust (Melcor REIT – TSX: MR.UN) today announced the results of its annual general meeting, held today. A total of 17,757,073 units were voted in person or by proxy, representing 61.05% of the outstanding units as of the record date. Unitholders approved all items of business before the AGM, including the election of trustees as follows:Nominee Votes For % VotesFor Votes Withheld % VotesWithheldBarry James 17,648,517 99.39% 107,556 0.61%Richard Kirby 17,065,987 96.11% 690,086 3.89%Bernie Kollman 17,078,937 96.19% 677,136 3.81%Brandon Kot 17,657,717 99.45% 98,356 0.55%Andrew Melton 17,078,887 96.19% 677,186 3.81%Naomi Stefura 17,094,787 96.28% 661,286 3.72%Ralph Young 17,106,787 96.34% 649,286 3.66%About Melcor REITMelcor...

Continue reading

Lifeist Wellness Inc. Signs Agreements with Simply Solventless Concentrates Ltd.

Lifeist enters into services agreement with Simply Solventless to provide operational support to CannMart and share purchase agreement to sell CannMart TORONTO, June 25, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that each of the Company and CannMart Inc. (“CannMart”), the Company’s wholly owned Ontario subsidiary, has entered into a services agreement (the “Services Agreement”) and a share purchase agreement (the “SPA”) each dated June 25, 2024 with Simply Solventless Concentrates Ltd. (TSXV: HASH, hereinafter “SSC”), an arm’s length party, for SSC to provide operational support services to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.